UniProtKB/Swiss-Prot Q5VTY9: Variant p.Asn450Ser

Protein-cysteine N-palmitoyltransferase HHAT
Gene: HHAT
Feedback?

Variant information Variant position:

450 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Asparagine (N) to Serine (S) at position 450 (N450S, p.Asn450Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (N) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In a lung cancer cell line. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs147954610 [ dbSNP | Ensembl ]

Sequence information Variant position:

450 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

493 The length of the canonical sequence.
Location on the sequence:

ALASCSTSMLILSNLVFLGG N EVGKTYWNRIFIQGWPWVTL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ALASCSTSMLILSNLVFLGGNEVGKTYWNRIFIQGWP-WVTL

Mouse                         LLAACSTSMLILFNLVFLGGIQVGKTYWNRIFLQGWP-WVT

Drosophila                    MLATQLFIPAAFSNVYFIGGQEIGDFLMRGAYLSGVGNYVA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 493	Protein-cysteine N-palmitoyltransferase HHAT
Topological domain	449 – 462	Lumenal
Binding site	448 – 455
Alternative sequence	416 – 451	ARYFSPQARRRFHAALASCSTSMLILSNLVFLGGNE -> VSRILAPVLGDSGTRQIRFIRDGAIRFPAPTMGPFY. In isoform 4.
Helix	450 – 460

Literature citations
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.
Kawakami Y.; Wang X.; Shofuda T.; Sumimoto H.; Tupesis J.; Fitzgerald E.; Rosenberg S.;
J. Immunol. 166:2871-2877(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3); TISSUE SPECIFICITY; GTP-BINDING; CHARACTERIZATION OF VARIANT GLU-448; VARIANT SER-450;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.